Case report: Robust response to sintilimab in advanced distal cholangiocarcinoma with PD-L1 expression and DNA damage repair
Cholangiocarcinoma (CCA) is a highly heterogeneous tumor that occurs in the bile duct epithelium; adenosquamous carcinoma is a rare pathological subtype of CCA. The clinical treatment of patients with metastatic distal CCA poses significant challenges. We report a 53-year-old female diagnosed with a...
Na minha lista:
Principais autores: | Wenguang He (Autor), Congcong Song (Autor), Jiwei Ren (Autor), Xiao Ji (Autor), Xiuyan Wang (Autor), Lixia Liu (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
por: Nan Zhou, et al.
Publicado em: (2023) -
Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
por: Lulu Xie, et al.
Publicado em: (2022) -
A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA repair and temozolomide drug resistance
por: Ying-Qi Song, et al.
Publicado em: (2023) -
The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
por: Jiahui Zhu, et al.
Publicado em: (2022) -
Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression
por: Hejing Bao, et al.
Publicado em: (2024)